American Society of Hematology 2020 Podcast Collection: Graft-Versus-Host Disease
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Fatobene G, Rocha V, Martin A, Hamadani M, Robinson S, Bashey A
. Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR. J Clin Oncol. 2020; 38(14):1518-1526.
PMC: 7213591.
DOI: 10.1200/JCO.19.02408.
View
2.
Sanz J, Galimard J, Labopin M, Afanasyev B, Angelucci E, Ciceri F
. Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT. J Hematol Oncol. 2020; 13(1):46.
PMC: 7201995.
DOI: 10.1186/s13045-020-00882-6.
View
3.
Kanate A, Mussetti A, Kharfan-Dabaja M, Ahn K, DiGilio A, Beitinjaneh A
. Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors. Blood. 2015; 127(7):938-47.
PMC: 4760094.
DOI: 10.1182/blood-2015-09-671834.
View
4.
Saber W, Le Rademacher J, Sekeres M, Logan B, Lewis M, Mendizabal A
. Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood.... Biol Blood Marrow Transplant. 2014; 20(10):1566-72.
PMC: 4169902.
DOI: 10.1016/j.bbmt.2014.06.010.
View
5.
Mielcarek M, Furlong T, ODonnell P, Storer B, McCune J, Storb R
. Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation. Blood. 2016; 127(11):1502-8.
PMC: 4797026.
DOI: 10.1182/blood-2015-10-672071.
View